UNSPSC 51111727: Amsacrine

This classification denotes an intercalating agent with the molecular formula C21H19N3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 00DPD30SOY, chemically known as methansulfon-m-aniside, 4-(9-acridinylamino)-, monohydrochloride but generally known as amsacrine, which bears US NIH Compound Identifier 2179. Amsacrine most often comes in hydrochloride and lactate forms. European Medicines Agency schedules Amsacrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05495MIG.

UNSPSC 51111727 Amsacrine is a Commodity code for a specific chemotherapy agent, but the recent state and local opportunities tagged under this code do not reflect procurement of amsacrine itself. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC through the MMCAP Infuse consortium for Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets; Seminole County, Florida issued an IFB for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually for community health initiatives. Neither opportunity involves amsacrine procurement. The code shows little relevant recent activity aligned to its nominal scope. State and local health departments and county health agencies use pharmaceutical piggyback contracts and competitive bidding to source specific drug products for clinical use, but the two opportunities in the recent record are misaligned with the amsacrine code classification.

Geographic activity in the recent record appears limited to Illinois and Florida, with no additional jurisdictions represented. The Illinois Department of Public Health opportunity (Bid 26-482DPH-PREPD-B-53392, completed award on August 28, 2026) supplied two antibiotic formulations under a 12-month initial term with renewal options. The Seminole County opportunity (IFB 60459723LAS, response due July 26, 2023) was posted June 30, 2026 and sought quarterly delivery of naloxone and drug deactivation systems to the Seminole County Community Health Building in Sanford. Neither solicitation is actively open for response. The mismatch between the amsacrine code label and the actual pharmaceutical products being procured suggests this code may be incorrectly applied in state and local procurement systems or that amsacrine itself does not see regular state and local solicitation activity.